IL150200A0 - Substituted pyrroles - Google Patents

Substituted pyrroles

Info

Publication number
IL150200A0
IL150200A0 IL15020000A IL15020000A IL150200A0 IL 150200 A0 IL150200 A0 IL 150200A0 IL 15020000 A IL15020000 A IL 15020000A IL 15020000 A IL15020000 A IL 15020000A IL 150200 A0 IL150200 A0 IL 150200A0
Authority
IL
Israel
Prior art keywords
substituted pyrroles
pyrroles
substituted
Prior art date
Application number
IL15020000A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL150200A0 publication Critical patent/IL150200A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL15020000A 1999-12-22 2000-12-21 Substituted pyrroles IL150200A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17155799P 1999-12-22 1999-12-22
PCT/EP2000/013026 WO2001046178A2 (en) 1999-12-22 2000-12-21 Substituierte bisindolymaleimide

Publications (1)

Publication Number Publication Date
IL150200A0 true IL150200A0 (en) 2002-12-01

Family

ID=22624198

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15020000A IL150200A0 (en) 1999-12-22 2000-12-21 Substituted pyrroles

Country Status (28)

Country Link
US (1) US6281356B1 (hr)
EP (1) EP1242409A2 (hr)
JP (1) JP2003518112A (hr)
KR (1) KR100508741B1 (hr)
CN (1) CN1193027C (hr)
AR (1) AR027035A1 (hr)
AU (1) AU782920B2 (hr)
BR (1) BR0016516A (hr)
CA (1) CA2394852A1 (hr)
CO (1) CO5090902A1 (hr)
CZ (1) CZ20022492A3 (hr)
HK (1) HK1054382A1 (hr)
HR (1) HRP20020536A2 (hr)
HU (1) HUP0204572A3 (hr)
IL (1) IL150200A0 (hr)
JO (1) JO2199B1 (hr)
MA (1) MA26860A1 (hr)
MX (1) MXPA02006162A (hr)
MY (1) MY133682A (hr)
NO (1) NO20022927D0 (hr)
NZ (1) NZ519359A (hr)
PE (1) PE20011098A1 (hr)
PL (1) PL357603A1 (hr)
RU (1) RU2261862C2 (hr)
UY (1) UY26498A1 (hr)
WO (1) WO2001046178A2 (hr)
YU (1) YU46302A (hr)
ZA (1) ZA200204313B (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
PE20040079A1 (es) 2002-04-03 2004-04-19 Novartis Ag Derivados de indolilmaleimida
GB0303319D0 (en) 2003-02-13 2003-03-19 Novartis Ag Organic compounds
NZ630875A (en) 2013-03-15 2017-12-22 Plexxikon Inc Heterocyclic compounds and uses thereof
US20140303121A1 (en) 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
EP3272745B1 (en) * 2016-07-21 2019-06-26 Instytut Farmakologii Polskiej Akademii Nauk Imidazolyl-substituted indole derivatives binding 5-ht7 serotonin receptor and pharmaceutical compositions thereof
CN111194318B (zh) 2017-10-13 2023-06-09 Opna生物公司 用于调节激酶的化合物固体形式

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
EP0630242B1 (en) * 1992-03-20 1999-01-20 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
AU3761393A (en) 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
PE91698A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PT1064279E (pt) * 1998-03-17 2003-10-31 Hoffmann La Roche Bisindolilmaleimidas substituidas para a inibicao da proliferacao celular

Also Published As

Publication number Publication date
BR0016516A (pt) 2002-09-17
WO2001046178A2 (en) 2001-06-28
CN1193027C (zh) 2005-03-16
UY26498A1 (es) 2001-06-29
JP2003518112A (ja) 2003-06-03
NO20022927L (no) 2002-06-18
NZ519359A (en) 2004-04-30
RU2261862C2 (ru) 2005-10-10
CZ20022492A3 (cs) 2003-02-12
US6281356B1 (en) 2001-08-28
KR100508741B1 (ko) 2005-08-17
PE20011098A1 (es) 2001-10-26
ZA200204313B (en) 2003-08-29
HK1054382A1 (en) 2003-11-28
HUP0204572A2 (en) 2003-05-28
AU782920B2 (en) 2005-09-08
EP1242409A2 (en) 2002-09-25
MY133682A (en) 2007-11-30
HUP0204572A3 (en) 2004-07-28
YU46302A (sh) 2005-06-10
MA26860A1 (fr) 2004-12-20
HRP20020536A2 (en) 2004-08-31
JO2199B1 (en) 2003-12-23
WO2001046178A3 (en) 2001-12-06
CO5090902A1 (es) 2001-10-30
RU2002119557A (ru) 2004-01-10
CA2394852A1 (en) 2001-06-28
PL357603A1 (en) 2004-07-26
CN1411457A (zh) 2003-04-16
AR027035A1 (es) 2003-03-12
NO20022927D0 (no) 2002-06-18
MXPA02006162A (es) 2002-12-05
AU3726701A (en) 2001-07-03
KR20020062365A (ko) 2002-07-25

Similar Documents

Publication Publication Date Title
DE60018571D1 (en) Hernienprothese
DE60033307D1 (en) Heteroalkylamino-substituierte bicyclische stickstoffheterocyclen
DE60008112D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE50002490D1 (en) Polyester-polyetherblockcopolymere
DE60008382D1 (en) Respiratorisches syncytialvirus replikation inhibitoren
DE60037335D1 (en) Polymerizationsverfahren
DE50008011D1 (en) Thixotropierungsmittel
DE60027722D1 (en) Aspartyl-protease inhibitoren
DE50002614D1 (en) Sigma-delta-modulator
DE60034237D1 (en) Ferrofluidabdichtung
DE60007505D1 (en) Propargyletherderivate
DE60028360D1 (en) Ptk-chipthermistor
DE60036727D1 (en) Differentialverstärker
DE50000137D1 (en) Spirofluorenopyrane
DE60011809D1 (en) Oxcarbazepinsuspension
DE59909975D1 (en) Testleck
DE60001313D1 (en) Imidazodiazepinderivate
DE60012950D1 (en) Polyacetalharzzusammensetzung
DE50009469D1 (en) Common-rail-injektor
IL150200A0 (en) Substituted pyrroles
HK1048307A1 (zh) 取代的雜環基-2h-苯並吡喃類化合物
DE50010757D1 (en) Stilbenaufheller
DE50012999D1 (en) Stirnwandisolation
DE60037536D1 (en) Polypeptidhormon phosphatonin
DE50008218D1 (en) Common-rail-injektor